Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Clinical trial NCT04170153 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04170153
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2026-11-30
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.